When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EVOK - FDA OKs Evoke Pharma's metoclopramide for diabetic gastroparesis
Evoke Pharma Inc.
The FDA approves Evok Pharma's (EVOK+2.6%) Gimoti (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis, a disorder in which the stomach's contractions are disrupted compromising digestion.
More news on: Evoke Pharma, Inc., Healthcare stocks news, Stocks on the move,